Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.

PARIS--(BUSINESS WIRE)--Acticor Biotech, (ISIN: FR0014005OJ5 - ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular ...

Brainomix announced today that it added $6.5 million (£4.8 million) in an extension to its Series C financing round.

Additional funding will enhance Brainomix's industry-leading customer support and fast-track product advancements across its Brainomix 360 Stroke and e-Lung AI imaging platforms.

The TESLA trial was unable to support a benefit to thrombectomy for stroke patients with large-core infarcts identified on noncontrast CT within 24 hours. Unlike other studies, endovascular therapy in ...

A stroke — either a blockage of blood flow to the brain or bleeding in the brain — is a medical emergency that requires immediate treatment. The two types of stroke are treated differently but can ...

The clinical syndrome produced by a stroke is determined by the artery or arteries that are occluded. Blood is supplied to the brain by two major sets of arteries, the anterior and posterior ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance ...

Advanced brain imaging is expanding stroke treatment windows, enabling selected patients beyond 24 hours to benefit ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...